Celularity Inc

Ownership Transactions Reported by 26 Insiders

Symbol
CELU, CELUW on Nasdaq
Location
170 Park Ave, Florham Park, New Jersey

Insiders trading volume in the past year

Celularity Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lim Kok Thay 10%+ Owner $12.9M +$8.06M +168% Mar 13, 2024
Robert J. Hariri Chief Executive Officer $11.7M +$2.98M +34.1% Apr 13, 2024
Dragasac Ltd 10%+ Owner $7.49M Jul 16, 2021
Starr International Co Inc 10%+ Owner $3.81M Mar 1, 2022
Sorrento Therapeutics, Inc. 10%+ Owner $1.26M Sep 29, 2023
Adrian Kilcoyne Chief Medical Officer $487K Feb 16, 2024
Genting Berhad 10%+ Owner $375K Jun 20, 2023
Peter Diamandis Director $325K Jun 14, 2023
John Sculley Director $250K Jun 14, 2023
John R. Haines Senior EVP, Chief Administrative Officer $158K Apr 13, 2024
David C. Beers Chief Financial Officer $98.6K Apr 13, 2024
Bradley Glover Executive Vice President, Chief Operating Officer $87.4K Apr 13, 2023
Kyle Fletcher Executive Vice President, General Counsel $86.7K Apr 13, 2024
Andrew C. Von Eschenbach Director $83.7K Jun 14, 2023
Stephen Brigido Pres, Functional Regeneration $80K Apr 13, 2024
Robin L. Smith Director $58.8K Jun 14, 2023
Dean C. Kehler Director $58.8K Jun 14, 2023
Marc Mazur Director $58.8K Jun 14, 2023
Diane Parks Director $58.8K Jun 14, 2023
GX Sponsor LLC 10%+ Owner $24.9K Jul 16, 2021
Anne Jones Chief Business Officer $12.2K Jul 13, 2022
Keary Dunn General Counsel & Executive Vice President $4.09K Apr 13, 2022
Beloo Mirakhur EVP, Clinical Development Sep 13, 2021
Geoffrey M.D. Ling Director Aug 31, 2023
Jay R. Bloom Director Sep 9, 2021
Andrew L. Pecora President Sep 15, 2021

Recent Insider Transactions by Companies or Individuals for Celularity Inc

Insider Symbol Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership